Methyl 2-methyl-2-(4-nitrophenyl)propanoate, 97%, 1g

(1R)-((2S,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol, 95.0%, 1g

(2E)-3-(2-chlorophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Fmoc-D-Phe-OH, 99.00%, 1g

tert-Butyl 1-(furan-2-ylmethyl)pyrrolidine-2-carboxylate, 95.0%, 5g

Ethyl 2-chloro-5-nitroisonicotinate, 97.0%, 1g

2-[5-amino-3-(2-thienyl)-1H-pyrazol-1-yl]-6-methylpyrimidin-4(3H)-one, 95.0%, 250mg

(S)-6,7-Dihydro-5H-cyclopenta[b]pyridin-5-ol, 98%, 5g

4-Bromo-1-methyl-3-(pyrrolidin-1-yl)-1h-pyrazole, 98%, 10g

Phenoxycycloposphazene, 98%, 1kg

4-(4-Bromophenyl)-5-methyl-1,3-thiazol-2-ylamine, 95.0%, 5g

Hydride terminated polydimethylsiloxane cSt 7-10, 100g

N-[3-(Dimethylamino)propyl]acrylamide (stabilized with MEHQ)>98.0%(GC)(T)100g